Evidence map›Paper›PMID 32944407›Full record

Trial reportCancer biology & medicine2020

Outcomes of patients treated with SVILE

Liqiang Wei, Lei Yang, Jin Ye, Jia Cong, Xin Li, Na Yao, Jing Yang, Xueying Cui, Jing Ding, Yiping Wu and 1 more

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cancer biology & medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Liqiang WeiDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Lei YangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Jin YeDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Jia CongDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Xin LiDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Na YaoDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Jing YangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Xueying CuiDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Jing DingDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Yiping WuDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Jingwen WangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.ORCID 0000-0002-9461-2301
Capital Medical University · CNBeijing Tongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyConsolidation ChemotherapyDeoxycytidineDisease-Free SurvivalFemaleHumansLymphoma, Extranodal NK-T-CellMaleMiddle AgedNeoplasm StagingNose NeoplasmsOrganoplatinum CompoundsDeoxycytidineOrganoplatinum CompoundschemotherapyExtranodal natural killer/T-cell lymphomanasal typeoverall responseradiotherapy

Identifiers

PMID32944407
PMCPMC7476087
OpenAlexW3087215331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.